British drugmaker AstraZeneca said on Tuesday its diabetes drug Farxiga was succ...
- British drugmaker AstraZeneca said on Tuesday its diabetes drug Farxiga was successful in reducing the risk of death by heart attack or the worsening of a type of heart failure in a late-stage clinical trial.
Farxiga met the main goal of the DAPA-HF trial which tested the medicine, in addition to the standard treatment, in patients whose heart cannot pump enough blood. The trial included patients with and without type-2 diabetes. Diabetes is associated with a high risk of heart failure. Heart failure affects about 64 million people worldwide and half of patients die within five years of diagnosis, AstraZeneca said.
“The result will also reinforce Farxiga’s utility in diabetes at a time when oral GLP-1 might enter the market,” they added, referring to a rival group of drugs.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Failure to test out combinations could cost England-WoodwardEngland's failure to experiment with different combinations in their 13-6 W...
Consulte Mais informação »
5 people injured after dump truck crashes into Seattle Subway restaurantThe truck allegedly had 'a catastrophic mechanical failure,' according to the Seattle Police Department.
Consulte Mais informação »
James Corden Signs Deal to Host ‘Late Late Show’ Through 2022James Corden has signed a new deal with CBS which will see him stay on as host of “The Late Late Show” through 2022. The multi-talented Brit had been in advanced negotiations with the s…
Consulte Mais informação »
The Bath Priory Hotel & Spa, BathFour acres of country manor, but in the heart of a city
Consulte Mais informação »
Why the Women of Friends Seem So Much Tighter Than the MenWe've seen several reunions between the ladies in our favorite group of Friends, but where are the guys?
Consulte Mais informação »